Study analysis · Medicine · 2025
They live past 100—and their poop proves why.
People who live to 100 have a special mix of gut bacteria—more Firmicutes and Lactobacillus, less Bifidobacterium—that might help them stay healthy longer.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at the tiny bacteria in people's poop and noticed that super-old people had different bacteria than younger folks. But it didn't change anyone's bacteria to see if that made them live longer — so we can't say the bacteria caused the long life, just that they were different.
What’s the bottom line?
Scientists looked at the tiny bacteria in people’s poop to see what’s different in those who live past 90.
How strong is this study?
The scientists did a good job measuring the bacteria carefully, but they didn't ask people what they ate or how they lived, and only studied 47 people from one place. That means we can't be sure the results apply to everyone — it's like guessing what all kids like to eat based on just five kids in one school.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
24 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=47)+4.2/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 542 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization or intervention; it can only identify associations between gut microbiota features and longevity, not prove that the microbiota causes healthy aging or vice versa.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported; the study appears independently conducted with no industry involvement identified.
Independent Analysis Safeguards
- Sequencing was performed by KingMed Diagnostics, but analysis used standard open-source tools (QIIME, LEfSe, SPSS) and statistical methods described in detail.
- Data analysis protocols (OTU clustering, diversity indices, PERMANOVA, LEfSe) were fully documented and based on established bioinformatics pipelines.
- Raw data available upon reasonable request for independent verification.
The study was conducted at a public hospital with ethical approval and anonymized data handling. No author affiliations with industry or financial disclosures were provided, and no funder is named. While the sequencing was outsourced to a commercial lab (KingMed Diagnostics), there is no indication of their involvement beyond technical execution. The absence of a funding statement is a limitation, but no evidence of bias or industry influence was found.
Key takeaways
- 01
People over 90 had more types of gut bacteria, 2.44 times more Firmicutes than Bacteroidetes, and lots of Lactobacillus — but less Bifidobacterium than younger people.
- 02
This mix of bacteria may help them stay healthier longer by reducing inflammation and improving digestion.
Surprising findings
- Centenarians had significantly lower levels of Bifidobacterium than younger adults.Bifidobacterium is widely promoted as a 'youthful' and 'healthy' gut bacterium. This study shows the opposite: the longest-lived people had less of it, challenging the universal benefit narrative.
- The gut microbiome of centenarians was more stable and uniform across individuals than any other group.We assume aging leads to chaotic, unpredictable microbiomes. But here, the oldest group had the most consistent microbial profile—suggesting stability, not decline, defines longevity.
Practical takeaways
Eat more traditional fermented foods like kimchi, sauerkraut, or fermented rice wine—these may naturally boost Lactobacillus and support a stable gut ecosystem.
This study was done in one Chinese region with unique diets; results may not apply to people with different lifestyles, medications, or genetics.
medium confidenceStop obsessing over Bifidobacterium supplements if your goal is longevity—focus instead on overall microbial diversity and stability through varied plant-based foods.
Bifidobacterium may still be beneficial for digestion or immunity in younger people—this doesn't mean it's 'bad,' just not the key marker for extreme longevity in this population.
medium confidencePrioritize gut health as a long-term investment—microbial stability builds over decades, not weeks.
This study can't prove that changing your microbiome now will make you live to 100. It only shows a pattern in those who already did.
low confidenceWhy this study matters
The 2.44 Ratio That Defies Aging
Centenarians in Hezhou had a Firmicutes-to-Bacteroidetes ratio of 2.44—more than double that of the elderly (1.00) and over five times higher than children (0.42). This suggests their gut microbiome is optimized for energy efficiency and reduced inflammation.
Most people think 'more good bacteria = better health,' but this shows it's not about quantity—it's about balance. A specific microbial ratio might be a biological signature of extreme longevity.
Lactobacillus: The Longevity Superstar
Lactobacillus was significantly enriched in centenarians, while Bifidobacterium—a probiotic commonly marketed as essential for aging—was significantly lower. LEfSe analysis flagged Lactobacillus as a key microbial marker for this group.
This flips the script on probiotic marketing. If you're buying Bifidobacterium supplements to live longer, this study suggests you might be targeting the wrong bug.
Stability Over Diversity? The Secret Sauce
While centenarians had the highest microbial diversity (Chao1 and Shannon indices, p<0.05), their biggest surprise was intra-group stability—their gut bacteria were more consistent across individuals than any other age group.
It’s not just having good bugs—it’s having the *same* good bugs. This suggests a predictable, resilient microbial ecosystem that may protect against age-related decline.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at the tiny bacteria in people’s poop to see what’s different in those who live past 90.
Research results
People over 90 had more types of gut bacteria, 2.44 times more Firmicutes than Bacteroidetes, and lots of Lactobacillus — but less Bifidobacterium than younger people.
What this means - more context
This mix of bacteria may help them stay healthier longer by reducing inflammation and improving digestion.
This study investigates whether gut microbiota characteristics differ in long-lived individuals (≥90 years) compared to younger age groups to identify microbial markers of healthy aging.
Long-lived individuals in Hezhou, China, showed higher gut microbiota diversity and stability, a higher Firmicutes-to-Bacteroidetes ratio (2.44), and enriched Lactobacillus, but lower Bifidobacterium than younger or elderly adults.
Methods Used
Observational cohort study of 47 healthy participants (10 centenarians) across four age groups; fecal samples analyzed via 16S rRNA gene sequencing and LEfSe analysis for microbial composition and diversity.
Main Finding
Centenarians exhibited significantly higher microbial diversity (Chao1 and Shannon indices, P<0.05), a Firmicutes/Bacteroidetes ratio of 2.44 (vs. 0.42–1.00 in other groups), and enriched Lactobacillus, with reduced Bifidobacterium and greater intra-group microbial stability.
Confidence Level
Moderate — findings are statistically significant within the cohort but limited by small sample size, cross-sectional design, and lack of dietary or confounder control.
Study Flags
Red Flags
- •Small sample size (n=47 total, n=10 centenarians)
- •Cross-sectional design (cannot prove causation)
- •No control for diet, lifestyle, or medication use
Surprising Findings
Centenarians had significantly lower levels of Bifidobacterium than younger adults.
Bifidobacterium is widely promoted as a 'youthful' and 'healthy' gut bacterium. This study shows the opposite: the longest-lived people had less of it, challenging the universal benefit narrative.
Practical Takeaways
Eat more traditional fermented foods like kimchi, sauerkraut, or fermented rice wine—these may naturally boost Lactobacillus and support a stable gut ecosystem.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 542 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study looked at the tiny bacteria in people's poop and noticed that super-old people had different bacteria than younger folks. But it didn't change anyone's bacteria to see if that made them live longer — so we can't say the bacteria caused the long life, just that they were different.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Clear age-group stratification across the lifespan
- Use of standardized high-throughput 16S rRNA sequencing
- Rigorous bioinformatics analysis (LEfSe, alpha/beta diversity)
Weaknesses
- Small sample size limits statistical power
- Cross-sectional design prevents causal inference
- No measurement of diet, lifestyle, or environmental exposures
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at the tiny bacteria in people’s poop to see what’s different in those who live past 90.
Research results
People over 90 had more types of gut bacteria, 2.44 times more Firmicutes than Bacteroidetes, and lots of Lactobacillus — but less Bifidobacterium than younger people.
What this means - more context
This mix of bacteria may help them stay healthier longer by reducing inflammation and improving digestion.
This study investigates whether gut microbiota characteristics differ in long-lived individuals (≥90 years) compared to younger age groups to identify microbial markers of healthy aging.
Long-lived individuals in Hezhou, China, showed higher gut microbiota diversity and stability, a higher Firmicutes-to-Bacteroidetes ratio (2.44), and enriched Lactobacillus, but lower Bifidobacterium than younger or elderly adults.
Methods Used
Observational cohort study of 47 healthy participants (10 centenarians) across four age groups; fecal samples analyzed via 16S rRNA gene sequencing and LEfSe analysis for microbial composition and diversity.
Main Finding
Centenarians exhibited significantly higher microbial diversity (Chao1 and Shannon indices, P<0.05), a Firmicutes/Bacteroidetes ratio of 2.44 (vs. 0.42–1.00 in other groups), and enriched Lactobacillus, with reduced Bifidobacterium and greater intra-group microbial stability.
Confidence Level
Moderate — findings are statistically significant within the cohort but limited by small sample size, cross-sectional design, and lack of dietary or confounder control.
Study Flags
Red Flags
- •Small sample size (n=47 total, n=10 centenarians)
- •Cross-sectional design (cannot prove causation)
- •No control for diet, lifestyle, or medication use
Surprising Findings
Centenarians had significantly lower levels of Bifidobacterium than younger adults.
Bifidobacterium is widely promoted as a 'youthful' and 'healthy' gut bacterium. This study shows the opposite: the longest-lived people had less of it, challenging the universal benefit narrative.
Practical Takeaways
Eat more traditional fermented foods like kimchi, sauerkraut, or fermented rice wine—these may naturally boost Lactobacillus and support a stable gut ecosystem.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 542 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study looked at the tiny bacteria in people's poop and noticed that super-old people had different bacteria than younger folks. But it didn't change anyone's bacteria to see if that made them live longer — so we can't say the bacteria caused the long life, just that they were different.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Clear age-group stratification across the lifespan
- Use of standardized high-throughput 16S rRNA sequencing
- Rigorous bioinformatics analysis (LEfSe, alpha/beta diversity)
Weaknesses
- Small sample size limits statistical power
- Cross-sectional design prevents causal inference
- No measurement of diet, lifestyle, or environmental exposures
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The scientists did a good job measuring the bacteria carefully, but they didn't ask people what they ate or how they lived, and only studied 47 people from one place. That means we can't be sure the results apply to everyone — it's like guessing what all kids like to eat based on just five kids in one school.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
24 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=47)+4.2/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 542 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cohort study with no randomization or intervention; it can only identify associations between gut microbiota features and longevity, not prove that the microbiota causes healthy aging or vice versa.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported; the study appears independently conducted with no industry involvement identified.
Independent Analysis Safeguards
- Sequencing was performed by KingMed Diagnostics, but analysis used standard open-source tools (QIIME, LEfSe, SPSS) and statistical methods described in detail.
- Data analysis protocols (OTU clustering, diversity indices, PERMANOVA, LEfSe) were fully documented and based on established bioinformatics pipelines.
- Raw data available upon reasonable request for independent verification.
The study was conducted at a public hospital with ethical approval and anonymized data handling. No author affiliations with industry or financial disclosures were provided, and no funder is named. While the sequencing was outsourced to a commercial lab (KingMed Diagnostics), there is no indication of their involvement beyond technical execution. The absence of a funding statement is a limitation, but no evidence of bias or industry influence was found.